Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Vyvanse price, strengths & recalls

Brand of lisdexamfetamine (generic)

Pharmacies pay $370.40 for 30 capsules of Vyvanse 10 mg capsule this week, and from $370.28 to $370.75 across its 13 priced strengths and forms. The generic, lisdexamfetamine, costs pharmacies from $74.56. It is in shortage (limited availability). It has 11 recalls on record, none ongoing. Its official label last changed on May 6, 2026.

Limited availabilityBrand
Pharmacies pay$370.40for 30 capsules of 10 mg capsuleNo change in 4 weeks
Fair cash price
$436.46
Strengths
13
Makers
1
Updated
Nov 11

Vyvanse price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
10 mg capsule Brand$12.35$370.40 / 30 capsulesNo change-0.1%
20 mg capsule Brand$12.35$370.36 / 30 capsulesNo change-0.1%
30 mg capsule Brand$12.34$370.28 / 30 capsulesNo change-0.3%
40 mg capsule Brand$12.35$370.39 / 30 capsulesNo change-0.3%
50 mg capsule Brand$12.35$370.36 / 30 capsulesNo change-0.2%
60 mg capsule Brand$12.35$370.64 / 30 capsules-0.1%-0.1%
70 mg capsule Brand$12.35$370.52 / 30 capsulesNo change-0.2%
10 mg chewable tablet Brand$12.35$370.57 / 30 tablets-0.1%+0.1%
20 mg chewable tablet Brand$12.34$370.32 / 30 tablets-0.1%-0.1%
30 mg chewable tablet Brand$12.35$370.41 / 30 tabletsNo change-0.2%
40 mg chewable tablet Brand$12.35$370.62 / 30 tabletsNo change-0.1%
50 mg chewable tablet Brand$12.35$370.58 / 30 tablets-0.1%+0.1%
60 mg chewable tablet Brand$12.36$370.75 / 30 tablets-0.1%No change

The lowest cost per capsule is 30 mg capsule at $12.34. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Vyvanse vs generic lisdexamfetamine

Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:

StrengthBrandGenericBrand costs
10 mg capsule$370.40$76.264.9x
20 mg capsule$370.36$74.565x
30 mg capsule$370.28$86.544.3x
40 mg capsule$370.39$79.774.6x
50 mg capsule$370.36$81.844.5x
60 mg capsule$370.64$78.154.7x
70 mg capsule$370.52$78.154.7x
10 mg chewable tablet$370.57$113.713.3x
20 mg chewable tablet$370.32$129.672.9x
30 mg chewable tablet$370.41$116.003.2x
40 mg chewable tablet$370.62$125.213x
50 mg chewable tablet$370.58$110.413.4x
60 mg chewable tablet$370.75$107.293.5x
GenericLisdexamfetamine prices

Supply status: shortages & recalls

In shortage108 products are short or being discontinued
8 ongoing recalls11 recalls on record, latest Oct 12, 2016

Shortages

  • Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77)Mylan Pharmaceuticals Inc., a Viatris Company · Available · Updated Nov 3, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01)Elite Laboratories, Inc. · Limited Availability · Reason: Shortage of an active ingredient · Updated Nov 3, 2026Estimated recovery: TBD
  • Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01)Elite Laboratories, Inc. · Limited Availability · Reason: Shortage of an active ingredient · Updated Nov 3, 2026Estimated recovery: TBD
  • Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01)Elite Laboratories, Inc. · Limited Availability · Reason: Shortage of an active ingredient · Updated Nov 3, 2026Estimated recovery: TBD
  • Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01)Elite Laboratories, Inc. · Limited Availability · Reason: Shortage of an active ingredient · Updated Nov 3, 2026Estimated recovery: TBD
  • Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77)Mylan Pharmaceuticals Inc., a Viatris Company · Available · Updated Nov 3, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77)Mylan Pharmaceuticals Inc., a Viatris Company · Available · Updated Nov 3, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77)Mylan Pharmaceuticals Inc., a Viatris Company · Available · Updated Nov 3, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77)Mylan Pharmaceuticals Inc., a Viatris Company · Available · Updated Nov 3, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77)Mylan Pharmaceuticals Inc., a Viatris Company · Available · Updated Nov 3, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77)Mylan Pharmaceuticals Inc., a Viatris Company · Available · Updated Nov 3, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01)Elite Laboratories, Inc. · Limited Availability · Reason: Shortage of an active ingredient · Updated Nov 3, 2026Estimated recovery: TBD

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Class IIOngoingNov 5, 2025Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for...Sun Pharmaceutical Industries Inc · D-0144-2026Class IIOngoingNov 5, 2025Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for...Sun Pharmaceutical Industries Inc · D-0145-2026Class IIOngoingNov 5, 2025Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for...Sun Pharmaceutical Industries Inc · D-0146-2026Class IIOngoingNov 5, 2025Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for...Sun Pharmaceutical Industries Inc · D-0147-2026Class IIOngoingNov 5, 2025Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for...Sun Pharmaceutical Industries Inc · D-0148-2026Class IIOngoingNov 5, 2025Lisdexamfetamine Dimesylate CapsulesFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for...Sun Pharmaceutical Industries Inc · D-0149-2026

Showing the 6 most relevant of 11 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for vyvanse? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedMay 6, 2026
Version81 of 39
EffectiveApr 30, 2026
Read the label

These highlights do not include all the information needed to use VYVANSE safely and effectively. See full prescribing information for VYVANSE. VYVANSE® (lisdexamfetamine dimesylate) capsules, for oral use, CII VYVANSE® (lisdexamfetamine dimesylate) chewable tablets, for oral use, CII Initial U.S. Approval: 2007

This drug has a boxed warning

WARNING: ABUSE, MISUSE, AND ADDICTION

VYVANSE has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including VYVANSE, can result in overdose and death [see Overdosage (10)], and this risk is increased with higher doses or unapproved methods of administration, such as snorting or injection.

Before prescribing VYVANSE, assess each patient's risk for abuse, misuse, and addiction. Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug. Throughout VYVANSE treatment, reassess each patient's risk of abuse, misuse, and addiction and frequently monitor for signs and symptoms of abuse, misuse, and addiction [see Warnings and Precautions (5.1), Drug Abuse and Dependence (9.2)].

WARNING: ABUSE, MISUSE, AND ADDICTION

See full prescribing information for complete boxed warning.

VYVANSE has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including VYVANSE, can result in overdose and death (5.1, 9.2, 10):

Before prescribing VYVANSE, assess each patient's risk for abuse, misuse, and addiction.

Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug.

Throughout treatment, reassess each patient's risk and frequently monitor for signs and symptoms of abuse, misuse, and addiction.

Recent major changes (as listed on the label)

Indications and Usage (1) | 09/2025 |

Warnings and Precautions (5.5) | 09/2025 |

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA021977 · Takeda Pharms USA
First approved
February 23, 2007 (19 years ago)
Latest approved change
April 23, 2026
Approved label
PDF, Apr 24, 2026
Generic makers
21 approved generic applications on the market

Vyvanse questions

How much does vyvanse cost without insurance?

Pharmacies pay about $370.40 for 30 capsules of vyvanse 10 mg capsule ($12.35 per capsule). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $436.46. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Vyvanse?

Yes: lisdexamfetamine. Pharmacies pay from $74.56 for it. Compare lisdexamfetamine prices.

Is vyvanse in shortage?

Yes. 108 products are listed as in shortage or being discontinued (limited availability). See which ones.

Has vyvanse been recalled?

11 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the vyvanse label last change?

The official label was last updated on May 6, 2026 (version 81). See what changed.

Talk about vyvanse

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.